Pharma needs to pay closer attention to ensuring the integrity of its third-party relationships, writes Kathy Johnson, vice president life sciences, LexisNexis 9 April 2019
An Expert View looking at the key factors that will drive deal activity over the next year from Michael Jewell, partner, head of healthcare & life sciences at C 18 March 2019
Even if the UK parliament votes against ‘no deal’ on Wednesday, in the wacky world of Brexit, this cliff-edge scenario is still possible – so Stevens & Bolton p 13 March 2019
In recent years.the pharmaceutical industry has seen tremendous changes in the way it is expected to deliver new drugs to market.being under increasing pressure 5 March 2019
Aaron Hudson, vice president of marketing and clinical diagnostics, SCIEX, writes an expert view on the science that is often considered “closest to the phenoty 13 February 2019
Amanda Powell-Smith, chief executive of Forster Communications, outlines the opportunities for pharma companies choosing to follow new guidance on the UK corpor 4 February 2019
Ahead of the Falsified Medicines Directive (FMD) which comes into play on February 9, Christian Taylor, Serialization Business Consultant at Zetes, provides his 25 January 2019
Imogen Ireland, life sciences IP associate for law firm Hogan Lovells, raises some important issues relating to advances in artificial intelligence (AI) that dr 9 January 2019
Does the way artificial intelligence is used in pharma need to be reimagined? Irina Efimenko, chief executive of Russian analytics experts Semantic Hub, and Mik 20 December 2018
Although biosimilars have taken off in Europe, they have yet to gain traction in the USA, writes Anne Runyan, senior consultant of market access at MKO Global P 11 December 2018
An exclusive Expert View column written for The Pharma Letter by Thomas Cueni, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) 6 December 2018
Charlotte Tillett, partner, and Emily Hocken, trainee, at Stevens & Bolton, offer an Expert View on the significance of the UK Supreme Court ruling in Warner-La 28 November 2018
Just over 140 years ago.the world’s first industrial-sized research and development laboratory opened.As someone who’s devoted his working life to finding new r 27 November 2018
The success of any pre-clinical research program relies on selecting the right animal for a study, writes Emmanuel Gomas, European services manager at Envigo, i 21 November 2018
In an Expert View column, Stephen Bennett (pictured) and Mary Foord-Weston, from UK-based law firm Hogan Lovells, consider the questions that new oncology treat 16 November 2018
Drug companies.which have learned to live with advertisements calling out a litany of possible side effects for their drugs.may want to take a couple of aspirin 7 November 2018
In an Expert View column.Helen Westropp.managing partner of branding agency Coley Porter Bell.describes how tens of millions of dollars are wasted in M&A deals 5 November 2018
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.